Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease

BACKGROUND: Currently available treatments for Alzheimer’s disease (AD) can produce mild improvements in cognitive function, behavior, and activities of daily living in patients, but their influence on long-term survival is not well established. This study was designed to assess patient survival and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hager, Klaus, Baseman, Alan S, Nye, Jeffrey S, Brashear, H Robert, Han, John, Sano, Mary, Davis, Bonnie, Richards, Henry M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937252/
https://www.ncbi.nlm.nih.gov/pubmed/24591834
http://dx.doi.org/10.2147/NDT.S57909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937252/
https://www.ncbi.nlm.nih.gov/pubmed/24591834
http://dx.doi.org/10.2147/NDT.S57909

Ejemplares similares